NCT02462252: Phase IIA Open Label Study to Evaluate Efficacy and Safety of BL-8040 Followed by (hATG), Cyclosporine and Methyprednisolone in Adult Subjects With Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome |
|
|
| Completed | 2a | 11 | US | BL-8040, horse anti-thymocyte globulin (hATG), ATGAM, Methylprednisolone, Medrol, Solu-Medrol, Depo-Medrol, Cyclosporine, Sandimmune, Cyclosporine A | BioLineRx, Ltd. | Aplastic Anemia, Hypoplastic Myelodysplastic Syndrome | 11/20 | 11/20 | | |